These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9769887)

  • 21. Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.
    Boulos P; Sebaldt RJ; Goldsmith CH
    J Rheumatol; 2002 May; 29(5):1110-1. PubMed ID: 12022339
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteoporosis--current concepts.
    Das SK; Misra R; Ramakrishnan S; Maheshwari A
    J Assoc Physicians India; 2001 Oct; 49():1007-11. PubMed ID: 11848307
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of bone mass screening to prevent fractures.
    Flicker L
    Med J Aust; 1991 Jan; 154(2):135-40. PubMed ID: 1986192
    [No Abstract]   [Full Text] [Related]  

  • 24. Identifying the osteopenic patient and preventing worsening of the disease.
    Derman R
    Curr Womens Health Rep; 2003 Jun; 3(3):199-206. PubMed ID: 12734030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy of osteoporosis].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2263-4. PubMed ID: 14508549
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy.
    Song EK; Yeom JH; Shin HT; Kim SH; Shin WG; Oh JM
    J Clin Pharm Ther; 2006 Oct; 31(5):421-7. PubMed ID: 16958819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
    Menon KV; Angulo P; Boe GM; Lindor KD
    Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].
    MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529718
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis of osteoporosis and some related issues].
    Yu W
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):725-7. PubMed ID: 15949373
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
    Watts NB
    J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density assessment.
    Leffler SG; Vaccaro JP
    Med Health R I; 2000 Apr; 83(4):123-6. PubMed ID: 10821016
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial.
    Forsblad-d'Elia H; Carlsten H
    Ann Rheum Dis; 2011 Jun; 70(6):1167-8. PubMed ID: 21047910
    [No Abstract]   [Full Text] [Related]  

  • 33. Seeking clarification of osteoporosis guidelines.
    Sehmer J
    CMAJ; 2004 Oct; 171(9):1022; author reply 1022-3. PubMed ID: 15505246
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of osteoporosis--why? Who? How?].
    Siggelkow H; Hüfner M
    Med Klin (Munich); 1995 Nov; 90(11):639-44. PubMed ID: 8569632
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quality of bones].
    Qiu MC; Zhu M
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):723-4. PubMed ID: 15949372
    [No Abstract]   [Full Text] [Related]  

  • 36. [Osteoporosis treatment: the point of view of the gynecologist].
    Lopes P
    Contracept Fertil Sex; 1998 Jun; 26(6):408-11. PubMed ID: 9691516
    [No Abstract]   [Full Text] [Related]  

  • 37. [Osteoporosis therapy in general practice. Which measure should be included?].
    Abendroth K
    MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
    [No Abstract]   [Full Text] [Related]  

  • 38. Interpretation of bone densitometry.
    Genant HK
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):20S-25S. PubMed ID: 9273933
    [No Abstract]   [Full Text] [Related]  

  • 39. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 40. Seeking clarification of osteoporosis guidelines.
    de Lemos ML
    CMAJ; 2004 Oct; 171(9):1022; author reply 1022-3. PubMed ID: 15505245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.